Company · CIK 0001604821 · SIC 8071 — Services-Medical Laboratories · Nasdaq
Natera, Inc. · NTRA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 SForm 4 → | Sep 25, 9:35 pm EDT | Jonathan SheenaDirector | 18,064 | $388.01 | $7,008,972 | 9,000 | −66.7% | 10b5-1 |
| Sep 16, 2026 GForm 4 → | Sep 18, 9:35 pm EDT | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | 945 | — | — | 109,914 | — | |
| Sep 15, 2026 SForm 4 → | Sep 17, 9:35 pm EDT | Jonathan SheenaDirector | 9,150 | $351.49 | $3,216,145 | 221,314 | −3.97% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 16, 9:35 pm EDT | Matthew RabinowitzEXECUTIVE CHAIRMAN, Director | 102,000 | $341.15 | $34,797,271 | 0 | −100% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 11, 9:35 pm EDT | Matthew RabinowitzEXECUTIVE CHAIRMAN, Director | 50,000 | $327.97 | $16,398,267 | 2,225,394 | −2.20% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 9:35 pm EDT | Solomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS | 18,160 | $325.88 | $5,917,907 | 110,859 | −14.1% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 9:05 pm EDT | Steven Leonard ChapmanCEO AND PRESIDENT, Director | 1,698 | $320.99 | $545,041 | 98,199 | −1.70% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.